July 15, 2026

KRAS G12D–Mutated Metastatic Pancreatic Cancer: Zoldonrasib Plus Chemotherapy

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown high rates of activity when combined with standard first-line chemotherapy, ...

The ASCO Post

July 15, 2026

KRAS G12D–Mutated Metastatic Pancreatic Cancer: Zoldonrasib Plus Chemotherapy

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown high rates of activity when combined with standard first-line chemotherapy, ...

The ASCO Post

June 22, 2026

A Burning Question: Can Wildfire Smoke Drive Cancer Risk?

Exposure to wildfire smoke was associated with significantly elevated risks of several cancers, including lung, colorectal, breast, bladder, and blood cancers, according to evidence from the Prostate,...

The ASCO Post

June 22, 2026

A Burning Question: Can Wildfire Smoke Drive Cancer Risk?

Exposure to wildfire smoke was associated with significantly elevated risks of several cancers, including lung, colorectal, breast, bladder, and blood cancers, according to evidence from the Prostate,...

The ASCO Post

June 18, 2026

Advancing Clinical Trials and Decision-Making With Synthetic Real-World Data

Synthetic real-world data generated by AI can model treatment patterns and clinical outcomes across large patient cohorts while accelerating clinical trials and drug development, according to Eddy Saa...

The ASCO Post

June 18, 2026

Advancing Clinical Trials and Decision-Making With Synthetic Real-World Data

Synthetic real-world data generated by AI can model treatment patterns and clinical outcomes across large patient cohorts while accelerating clinical trials and drug development, according to Eddy Saa...

The ASCO Post

June 10, 2026

2026 ASCO Breakthrough Meeting to Highlight New Advances in Liquid Biopsy, Metabolic Risks, and Tailored Therapies for Asian Populations

The ASCO Breakthrough meeting being held in Singapore this month will bring together global oncology professionals in Asia to discuss the latest cancer research advances across multiple disease sites ...

The ASCO Post

June 10, 2026

2026 ASCO Breakthrough Meeting to Highlight New Advances in Liquid Biopsy, Metabolic Risks, and Tailored Therapies for Asian Populations

The ASCO Breakthrough meeting being held in Singapore this month will bring together global oncology professionals in Asia to discuss the latest cancer research advances across multiple disease sites ...

The ASCO Post

May 29, 2026

Behind the Scenes of the 2026 ASCO Annual Meeting

In an interview with The ASCO Post, Jo Chien, MD, Professor of Medicine at University of California, San Francisco, and Chair of the 2026 ASCO Annual Meeting Scientific Program Committee, peels back t...

The ASCO Post

May 29, 2026

Behind the Scenes of the 2026 ASCO Annual Meeting

In an interview with The ASCO Post, Jo Chien, MD, Professor of Medicine at University of California, San Francisco, and Chair of the 2026 ASCO Annual Meeting Scientific Program Committee, peels back t...

The ASCO Post